Viking Therapeutics, Inc. (VKTX)
24.77
-1.07
(-4.14%)
USD |
NASDAQ |
Nov 20, 16:00
25.14
+0.37
(+1.49%)
After-Hours: 20:00
Viking Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 83.88% |
| Ironwood Pharmaceuticals, Inc. | 99.66% |
| Compass Therapeutics, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 89.75% |
| MediciNova, Inc. | 37.81% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -110.0% |
| Return on Assets | -88.03% |
| Return on Invested Capital | -100.8% |
| Return on Net Operating Assets | -4.64K% |